| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 27-31 |
| Number of pages | 5 |
| Journal | Pharma Times |
| Volume | 45 |
| Issue number | 1 |
| Publication status | Published - 2013 |
Cite this
Moorkoth, S., Gujar, Y., & Bukka, D. (2013). Can India repeat the success of generics in US (United States) biosimilar market? an analysis of current FDA's stand on biosimilars. Pharma Times, 45(1), 27-31. https://www.scopus.com/inward/record.uri?eid=2-s2.0-84873849389&partnerID=40&md5=7245a0760ac0d3424399eb624a87fcd7